Over one trillion dollars have flowed into AI development as firms chase artificial super intelligence. Emilia Javorsky of the Future of Life Institute challenges the common narrative that these massive models are required to cure cancer. This critique suggests that current hype over AGI obscures the specific, targeted research actually needed for medical breakthroughs.